LANXESS Aktiengesellschaft (LXS) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of LANXESS Aktiengesellschaft €33.08, price €12.87, upside +157.0%, quality 42 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch LANXESS Aktiengesellschaft for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 23, 2026.
How to read this chart
60‑month range €11.58 – €60.80 · fair‑value band €18.69 – €47.47 · the €12.87 price screens below the €33.08 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 23, 2026.
Follow LANXESS Aktiengesellschaft in your weekly email
Every Wednesday you see whether LANXESS Aktiengesellschaft is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
LANXESS, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates.
Show more
LANXESS, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative solutions; flavors and fragrances; liquid purification technologies for the treatment of water and other liquids; and precursors and intermediates for the agrochemicals, pharmaceuticals, and specialty chemicals industries. It also offers additives, lubricants, flame retardants, plasticizers, and bromine derivatives for various rubber, plastic and paint, electrical/electronics, and construction industries. In addition, the company provides basic and fine chemicals, organometallics, and inorganic pigments for the coloring of construction materials, as well as paints and coatings. It serves the energy, natural resources, industrial applications, nutrition, health, consumer goods, agriculture, animal health, construction, chemicals, and mobility industries. LANXESS was founded in 1863 and is headquartered in Cologne, Germany.
Stock analysis
LANXESS Aktiengesellschaft (LXS) currently trades at €12.87, while our model-based Fair Value estimate is €33.08, implying the stock looks roughly 61.1% undervalued today.
Show more
Valuation
Bull case: the Multiples group reads highest at a median of €41.63 per share, and 2 of the 4 models we run sit above the €12.87 price.
Bear case: the Asset-Based group reads lowest at €27.12, and 2 of the 4 models stay below the price. Evidence for this calculation is medium.
Scenario range: €18.69 (bear) to €47.47 (bull), the price of €12.87 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 42/100 (below-average quality), in the Basic Materials sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
LANXESS Aktiengesellschaft reported revenue of €5.7B in FY2025 versus €7.6B in FY2021, a compound −6.9%/yr. Reported net income was −€577M in FY2025.
Key figures
Market cap €1.4B · P/S ratio 0.25 · EPS (TTM) €−7.65 · Dividend yield 0.8% · Net margin −10.2% · Return on equity −16.8% · Return on assets (EBIT) 0.4% · Operating margin −2.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 42 out of 100 (low confidence).
What moves the price
The share trades about 46% below its 52-week high and 11% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −40% fair-value upside, at 157%, LXS screens cheaper than that median.
Fair Value models
Bear €18.69Fair Value €33.08Bull €47.47
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.1/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−10.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−11.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.5%
Start year 2020 (pandemic). Over 10 years: −3.3% a year
Revenue growth 22 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.5%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
21.6% (2020) → −0.6% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
News mood ⓘNews mood, the average tone of recent news (85 articles), rated against how stocks are usually covered. 🚀 Hype = unusually upbeat · 🙂 Positive = above average · 😐 Neutral = typical · 🙁 Negative = below average · 😨 Very negative = unusually downbeat. It reflects the tone of coverage, not our valuation.Negative
Recent news coverage is more negative than average.
Compare LANXESS Aktiengesellschaft with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 714 stocks
Beats the industry median on 5/12 measures
A mixed picture versus its industry peers.
Valuation
Quality Score42 · Bottom 25%
Fair Value upside+157% · Top 25%
Profitability
Return on assets−1% · Bottom 25%
Net margin (TTM)−12% · Bottom 25%
Operating margin (TTM)−3% · Bottom 25%
Growth and dividend
Revenue growth−14% · Bottom 25%
Dividend yield (TTM)0.8% · Below median
Balance sheet
Debt / equity0.51× · Highest 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "LANXESS Aktiengesellschaft Fair Value". https://www.fairvalue-calculator.com/stock/LXS
Frequently asked questions
Is LANXESS Aktiengesellschaft (LXS) overvalued or undervalued?
As of Sep 23, 2026, our model estimates a fair value of €33.08 versus a price of €12.87, about +157% upside (undervalued).
What is the fair value of LXS?
Our model-based fair value for LANXESS Aktiengesellschaft is €33.08 (as of Sep 23, 2026), built from audited fundamentals. The current price: €12.87.
What is the quality score of LXS?
LANXESS Aktiengesellschaft has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for LANXESS Aktiengesellschaft (LXS)?
Our model-based price target is the fair value of €33.08 (as of Sep 23, 2026) from 4 valuation models. Cautious scenario €18.69, optimistic scenario €47.47. It is a calculation from audited fundamentals, not an analyst target.
What is the LANXESS Aktiengesellschaft stock forecast for 2026?
Our models put fair value at €33.08, about +157% upside versus a price of €12.87 (undervalued). Cautious scenario €18.69, optimistic scenario €47.47. The calculation is refreshed regularly with new filings.
What is the revenue of LANXESS Aktiengesellschaft (LXS)?
LANXESS Aktiengesellschaft reported trailing-twelve-month revenue of about €5.4B (latest available figure, as of Sep 23, 2026).
Does LANXESS Aktiengesellschaft pay a dividend?
LANXESS Aktiengesellschaft currently shows a dividend yield of about 0.78% relative to its recent price (as of Sep 23, 2026).
What is the intrinsic value of LANXESS Aktiengesellschaft (LXS)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For LANXESS Aktiengesellschaft it is €33.08 per share (as of Sep 23, 2026), against a price of €12.87. It is the blended result of 4 valuation models (cash flow, earnings, asset, dividend).
Is LANXESS Aktiengesellschaft stock overvalued or undervalued in 2026?
As of Sep 23, 2026, LXS trades below its calculated fair value: price €12.87, fair value €33.08, a gap of about +157% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of LXS?
No. The price is what the market pays today (€12.87); the fair value is what the company's own numbers justify (€33.08). For LANXESS Aktiengesellschaft the two are €20.21 per share apart. That gap is exactly why we show both numbers side by side.
How much is LANXESS Aktiengesellschaft worth?
The market values LANXESS Aktiengesellschaft at about €1.4B (market capitalisation, as of Sep 23, 2026). Per share that is €12.87; our models calculate a fair value of €33.08 per share.
What do the bullish and bearish scenarios say about LXS?
Our models span a range for LANXESS Aktiengesellschaft: cautious scenario €18.69, base €33.08, optimistic €47.47 per share (as of Sep 23, 2026, price €12.87). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of LXS?
The PEG ratio of LANXESS Aktiengesellschaft is 1.12 (P/E divided by earnings growth, as of Sep 23, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of LANXESS Aktiengesellschaft (LXS)?
Balance-sheet figures for LANXESS Aktiengesellschaft (as of Sep 23, 2026): return on equity −16.8%, debt of 0.51 per unit of equity. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is LXS from its 52-week high?
LANXESS Aktiengesellschaft trades at €12.87, about 46% below its 52-week high of €23.96 and 11% above the low of €11.58 (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of €33.08 is for.
Which stocks are comparable to LANXESS Aktiengesellschaft?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is LANXESS Aktiengesellschaft stock attractive at the current price?
The data as of Sep 23, 2026: price €12.87, calculated fair value €33.08 (+157%), Quality Score 42/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of LXS calculated?
We run LANXESS Aktiengesellschaft through 4 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €33.08, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. LANXESS Aktiengesellschaft currently trades 157 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of LANXESS Aktiengesellschaft (LXS)?
The closing price on Sep 23, 2026 was €12.87. Our model-based fair value is €33.08, about +157% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with LANXESS Aktiengesellschaft right now?
The large discount to fair value meets weak quality (42/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (€18.69). The market is more pessimistic than our downside scenario. A fairly wide model range (€18.69 to €47.47) leaves room in how you read the outcome.
Key figures of LANXESS Aktiengesellschaft
How large is the market capitalisation of LANXESS Aktiengesellschaft (LXS)?
The market capitalisation of LANXESS Aktiengesellschaft is €1.4B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of LANXESS Aktiengesellschaft (LXS)?
The price-to-sales ratio of LANXESS Aktiengesellschaft is 0.25 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of LANXESS Aktiengesellschaft (LXS)?
Earnings per share at LANXESS Aktiengesellschaft are €−7.65. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of LANXESS Aktiengesellschaft (LXS)?
The dividend yield of LANXESS Aktiengesellschaft is 0.8%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of LANXESS Aktiengesellschaft (LXS)?
The net margin of LANXESS Aktiengesellschaft is −10.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of LANXESS Aktiengesellschaft (LXS)?
The return on equity (ROE) of LANXESS Aktiengesellschaft is −16.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of LANXESS Aktiengesellschaft (LXS)?
On an EBIT basis the return on assets of LANXESS Aktiengesellschaft is 0.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of LANXESS Aktiengesellschaft (LXS)?
The operating margin of LANXESS Aktiengesellschaft is −2.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at LANXESS Aktiengesellschaft (LXS)?
Revenue at LANXESS Aktiengesellschaft is growing −13.9% versus a year earlier (3y avg −11.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at LANXESS Aktiengesellschaft (LXS)?
Earnings per share at LANXESS Aktiengesellschaft are growing +13.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does LANXESS Aktiengesellschaft (LXS) generate?
The free cash flow of LANXESS Aktiengesellschaft is −€56.0M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does LANXESS Aktiengesellschaft (LXS) carry?
The net debt of LANXESS Aktiengesellschaft is €2.1B (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch LANXESS Aktiengesellschaft in the live analysis
One click puts LANXESS Aktiengesellschaft on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
